Apitox
Inflammation and pain (e.g., Osteoarthritis)
Not DisclosedActive
Key Facts
Indication
Inflammation and pain (e.g., Osteoarthritis)
Phase
Not Disclosed
Status
Active
Company
About Lokathi Therapeutics
Lōkahi Therapeutics is a private, pre-revenue biotech leveraging a unique 'Actual Intelligence (ai²)' operating philosophy to identify and advance distressed or overlooked clinical assets. Its lead candidate, Apitox, targets inflammation and pain, initially in osteoarthritis, representing a non-opioid alternative in a large market. The company is actively seeking licensing and acquisition opportunities to build its pipeline and is led by a team with expertise in development, finance, and technology.
View full company profile